Consensus Illumina, Inc.

Stocks

ILMN

US4523271090

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 17:37:32 30/10/2026 +03			5-day change	1st Jan Change
248.38 ^USD	-14.37%		-5.95%	+93.18%

02:41pm	Bernstein Adjusts Price Target on Illumina to $250 From $215	MT
02:40pm	JPMorgan Adjusts Price Target on Illumina to $300 From $320	MT

Evolution of the Average Target: Illumina, Inc.

Evolution of the Target Price: Illumina, Inc.

Changes in Analyst Recommendations: Illumina, Inc.

25fef6b1b.aARpbBLLp5YgZTXZrdhuJx_4AKp9WDujyvOu1M9zSUQ.WmgGFHGU8uBqFQWPn4dfQlGMY_oiaw3kor__gaI6LSkbTlFbK7L-xlk8Rg~0fcf4fe66b7cc21f8f70db001860a853

Analysts' recommendations: Illumina, Inc.

02:41pm	Bernstein Adjusts Price Target on Illumina to $250 From $215	MT
02:40pm	JPMorgan Adjusts Price Target on Illumina to $300 From $320	MT
10-23	Stephens Downgrades Illumina to Equal Weight From Overweight, $275 Price Target	MT
10-19	Analyst recommendations: ConocoPhillips, Datadog, Intel, Fair Isaac, MGM Resorts…
10-14	JPMorgan Adjusts Price Target on Illumina to $320 From $230	MT
10-13	TD Cowen Adjusts Price Target on Illumina to $270 From $210	MT
10-08	Baird Adjusts Price Target on Illumina to $286 From $225	MT
10-08	Analyst recommendations: Constellation Brands, Etsy, Micron, Palantir, Hilton…
10-07	Evercore ISI Adjusts Price Target on Illumina to $290 From $225	MT
10-06	Barclays Adjusts Illumina Price Target to $200 From $160, Maintains Underweight Rating	MT
10-05	RBC Raises Price Target on Illumina to $310 From $230, Keeps Outperform Rating	MT
10-05	Analyst recommendations: Estee Lauder, Nike, Intel, Nvidia, Tesla…
10-01	Guggenheim Adjusts Price Target on Illumina to $305 From $226, Keeps Buy Rating	MT
09-29	Leerink Partners Adjusts Price Target on Illumina to $300 From $220, Keeps Outperform Rating	MT
09-28	Analyst recommendations: Datadog, PepsiCo, Roblox, Coinbase, Nike…
09-28	Piper Sandler Adjusts Price Target on Illumina to $305 From $225, Keeps Overweight Rating	MT
09-09	UBS Upgrades Illumina to Buy From Neutral, Adjusts Price Target to $260 From $135	MT
08-11	Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says	MT
07-31	RBC Raises Price Target on Illumina to $230 From $170, Keeps Outperform Rating	MT
07-13	Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth…
07-06	Analyst recommendations: Chubb, Delta Air Lines, Pfizer, AMD, Dow…
06-10	JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185	MT
05-15	Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says	MT
05-14	Daiwa Securities Upgrades Illumina to Outperform From Neutral, Adjusts Price Target to $155 From $128	MT
05-14	Analyst recommendations: Doximity, Reddit, Cisco, Whirlpool, Caterpillar…

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ILLUMINA, INC.					-14.19%
	THERMO FISHER SCIENTIFIC, INC.					+6.05%
	DANAHER CORPORATION					+9.67%
	INTUITIVE SURGICAL, INC.					+7.55%
	BOSTON SCIENTIFIC CORPORATION					+21.79%
	EDWARDS LIFESCIENCES CORPORATION					+7.86%
	SIEMENS HEALTHINEERS AG					+5.84%
	AGILENT TECHNOLOGIES, INC.					+0.5%
	VEEVA SYSTEMS INC.					-2.97%
	WATERS CORPORATION					-2.96%
	Average					+3.91%
	Weighted average by Cap.					+5.89%